Clinical trial: The HIt HArd and hiT Early in Multiple Sclerosis Trial - HiHat Trial A Phase 2 Study of Sequential Treatment With Rituximab and Cladribine for Relapsing-remitting Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07517185?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20390

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology